Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00129285 · ClinicalTrials.gov registry record · Phase 2
Modafinil Treatment for Cocaine-Dependent Individuals
A Phase 2 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 210
- Enrollment target
NCT00129285: Completed Phase 2 study, sponsored by University of Pennsylvania.
NCT00129285 is a Phase 2 study that has completed, run by University of Pennsylvania. The registered enrollment target is 210 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00129285, a Phase 2 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 210 participants
- Enrollment target
Study Summary
Despite years of active research, there are still no approved medications for the treatment of cocaine dependence. The purpose of this study is to determine the effectiveness of modafinil in treating cocaine-dependent individuals.
Interventions
- DRUG Placebo
- DRUG Low Dose Modafinil
- DRUG High Dose Modafinil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2004-07 |
| Est. Completion | 2008-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00129285
The ClinicalTrials.gov registry entry for NCT00129285 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00129285 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00129285 about?
NCT00129285 is a clinical study titled "Modafinil Treatment for Cocaine-Dependent Individuals". Despite years of active research, there are still no approved medications for the treatment of cocaine dependence. The purpose of this study is to determine the effectiveness of modafinil in treating cocaine-dependent individuals.
What is the current status of trial NCT00129285?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 210 participants. The study started on 2004-07. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00129285?
The interventions under investigation include: Placebo (DRUG), Low Dose Modafinil (DRUG), High Dose Modafinil (DRUG).
Who is sponsoring clinical trial NCT00129285?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.